Moderna Reports Major Miss on Q3 Earnings
Moderna reported a massive miss on revenue in its Q3 earnings, taking in $5 billion versus the expected $6.21 billion despite sales of the COVID-19 vaccine. The pharmaceutical giant's stock dropped sharply on the news.
More Videos
How Phantom Space Plans to Disrupt the Commercial Space Race
Jim Cantrell, Co-Founder and CEO of Phantom Space, explains how the company is working to make rocket launches faster, cheaper, and more scalable.
Meta and Microsoft Just Sent a Big AI Message to Investors
Big Tech is pouring billions into AI. Ray Wang, CEO of Constellation Research, explains what Meta and Microsoft's earnings reveal about those investments.
Can NYC Finally Cool Its Subway?
Why is the NYC subway platform so hot? One rider built his own sensor network to find out. We explore the geothermal fix the MTA is piloting right now.
Boeing's Big Test: Earnings, Deliveries, and the Road Ahead
Morningstar equity analyst Nicolas Owens explains Boeing's latest earnings, deliveries, rising fuel costs, and what they mean for airlines and investors.
Inside Five Star Franchising's Plan to Help the Next Generation of Business Owners
Five Star Franchising CEO Scott Abbott explains why Millennials and Gen Z are embracing franchise ownership and what it means for the future of work.
Businesses Older Than America: 250+ Year Old Companies Still Going Strong
These three American businesses existed before the country itself, and they're still thriving!
